Modern drug discovery environments depend on the quality and accuracy of results from in vitro and in vivo studies to select new chemical entities (NCEs) or new biological entities (NBEs) with a high potential for clinical success. Modern medicinal chemistry labs can synthesize compounds at a rapid rate, increasing throughput demands on ADME/PK labs.
Help your lab operate more efficiently in ADME workflows, by increasing the speed and quality of bioanalytical results. DiscoveryQuant 3.0 software will help you accomplish:
DiscoveryQuant 3.0 software is:
Screenshot of the DiscoveryQuant 3.0 software for compound optimization review. The software automatically chooses the best transitions and optimizes the MS parameters for maximal sensitivity in detection. Optimized parameters are saved in a global database and can be shared across lab sites for fast method transfer.